Proliferative capacity exhibited by human liver-resident CD49a+CD25+ NK cells

PLoS One. 2017 Aug 9;12(8):e0182532. doi: 10.1371/journal.pone.0182532. eCollection 2017.

Abstract

The recruitment and retention of Natural Killer (NK) cells in the liver are thought to play an important role during hepatotropic infections and liver cirrhosis. The aims of this study were to determine differences between liver-derived and peripheral blood-derived NK cells in the context of liver inflammation and cirrhosis. We conducted a prospective dual-center cross-sectional study in patients undergoing liver transplantation or tumor-free liver resections, in which both liver tissue and peripheral blood samples were obtained from each consenting study participants. Intrahepatic lymphocytes and PBMCs were stained, fixed and analyzed by flow cytometry. Our results showed that, within cirrhotic liver samples, intrahepatic NK cells were particularly enriched for CD49a+ NK cells when compared to tumor-free liver resection samples. CD49a+ liver-derived NK cells included populations of cells expressing CD25, CD34 and CXCR3. Moreover, CD49a+CD25+ liver-derived NK cells exhibited high proliferative capacity in vitro in response to low doses of IL-2. Our study identified a specific subset of CD49a+CD25+ NK cells in cirrhotic livers bearing functional features of proliferation.

MeSH terms

  • Adult
  • Aged
  • Antigens, CD34 / physiology
  • Cell Proliferation / physiology*
  • Cross-Sectional Studies
  • Female
  • Flow Cytometry
  • Humans
  • Integrin alpha1 / physiology*
  • Interleukin-2 Receptor alpha Subunit / physiology*
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / physiology*
  • Liver / cytology*
  • Liver / immunology
  • Liver / physiology
  • Liver Transplantation
  • Male
  • Middle Aged
  • Prospective Studies
  • Receptors, CXCR3 / physiology

Substances

  • Antigens, CD34
  • CXCR3 protein, human
  • IL2RA protein, human
  • Integrin alpha1
  • Interleukin-2 Receptor alpha Subunit
  • Receptors, CXCR3

Grants and funding

MA received founding support from the Deutsche Forschungsgemeinschaft (SFB841). CS and TP received founding support from the: Helmut and Hannelore Greve Foundation, http://www.awhamburg.de/en/academy/portrait/funding.html; YAEL Foundation (https://yael-stiftung.de/en/home); TK, HG and LH were financially supported by the Graduiertenkolleg (GRK) from the University Medical Center Hamburg-Eppendorf (UKE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.